Genetically engineered stem cell-derived retinal grafts for improved retinal reconstruction after transplantation

Area of Science:

• Regenerative Medicine
• Neuroscience
• Ophthalmology

Background:

• Retinal sheet transplantation using embryonic stem cells (ESC) or induced pluripotent stem cells (iPSC) shows promise for restoring vision.
• These grafts supply photoreceptors and other retinal cells, aiding visual function recovery in models of retinal degeneration.

Purpose of the Study:

• To investigate the efficacy of genetically engineered ESC/iPSC-retinal sheets with modified cell composition for retinal transplantation.
• To reinforce evidence for synaptic integration, functional recovery, and reduced aberrant neural activity following transplantation.

Main Methods:

• Development of genetically engineered mouse ESC/iPSC-retinal sheets with reduced secondary retinal neurons but intact photoreceptor layers.
• Transplantation of these engineered sheets into mice with end-stage retinal degeneration.
• Assessment of synaptic connections, light responsiveness, and retinal ganglion cell activity.

Main Results:

• ESC/iPSC-retinal sheet transplantation successfully established synaptic connections with the host retina.
• Transplanted mice showed restored light responsiveness and reduced aberrant retinal ganglion cell spiking.
• Genetically engineered grafts significantly improved neural integration and visual recovery outcomes.

Conclusions:

• ESC/iPSC-retinal sheet transplantation is a viable strategy for treating retinal degeneration.
• Genetic engineering of grafts enhances neural integration and visual recovery by modulating host neural activity.
• Optimized graft composition can lead to improved therapeutic outcomes in retinal regenerative medicine.